Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00256698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

514

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Fulvestrant
DRUG: Anastrozole

Sponsor

AstraZeneca